|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.11 USD | -0.47% |
|
-0.47% | -2.31% |
PharmaCyte Biotech, Inc. (NasdaqCM:PMCB) announces a share repurchase program. Under the offer, the company will repurchase up to 7,750,000 shares, at a purchase price of $3.25 per share. The purchase of common stock in connection with the tender offer will be funded entirely through the Company’s cash on hand.
The offer will expire on June 9, 2023.
| 1st Jan change | Capi. | |
|---|---|---|
| -2.31% | 17.84M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
PHARMACYTE BIOTECH, INC. 
